Clinical Trial

Women at Risk of Breast Cancer and OLFM4

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Does the olfactomédine provide an help to limit the number of false positives in the overall imaging balance and limit the number of unnecessary biopsies?
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2016-01-11; most recent amendment 2025-08-11.
Status change: Recruiting → Active, Not Recruiting 2025-08-11
Status change: Not Yet Recruiting → Recruiting 2019-01-04
Trial Details
NCT Number NCT02653105
Lead Sponsor Institut Cancerologie de l'Ouest
Conditions Hereditary Breast and Ovarian Cancer Syndrome
Enrollment 150 participants
Start Date 2016-03-08
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-08-15